Viewing Study NCT03300505


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-03-11 @ 1:01 AM
Study NCT ID: NCT03300505
Status: TERMINATED
Last Update Posted: 2025-05-13
First Post: 2017-09-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Sponsor:
Organization: